Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: An experience from a tertiary care center in northern India

Indian Journal of Gastroenterology

Volumn 26, Issue 6, 2007, Pages 274-278

  Paul, Shashi Bala ^a   Sreenivas, Vishnubhatla ^a   Gulati, Manpreet Singh ^a   Madan, Kaushal ^a   Gupta, Arun Kumar ^a   Mukhopadhyay, Sima ^a   Panda, Subrat Kumar ^a   Acharya, Subrat Kumar ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; AUTOIMMUNE DISEASE; CANCER INCIDENCE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INDIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; TERTIARY HEALTH CARE;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; INCIDENCE; INDIA; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 43049118250     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-17.
2. Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-85.
3. Pisani P, Parkin DM, Ferlay J. Estimates of the world wide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993;55:891-3.
4. Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, et al. Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B: the EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 1995;21:77-82.
5. Acharya SK, Sharma PK, Singh R, Mohanty SK, Madan K, Jha JK, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007;46:387-394.
6. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarathy S, et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997;51:167-74.
7. Panigrahi AK, Roca J, Acharya SK, Jameel S, Panda SK. Genotype determination of hepatitis C virus from northern India: identification of a new subtype. J Med Virol 1996;48:191-8.
8. Chaudhuri V, Tayal R, Nayak B, Acharya SK, Panda SK. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 2004;127:1356-71.
9. Hazari S, Acharya SK, Panda SK. Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control. J Virol Methods 2004;116:45-54.
10. Lwanga SK, Lemeshow S. WHO's Sample Size Determination in Health Studies. A Practical Manual. Geneva 1991.
11. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. European Association for the study of liver. J Hepatol 2001;35:421-30.
12. Dhir V, Mohandas KM. Epidemiology of digestive tract cancers in India III. Liver. Indian J Gastroenterol 1998;17:100-3.
13. Indian Council of Medical Research. National Cancer Registry Programme. Consolidated report of the population-based cancer registries. New Delhi, 1997.
14. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273-8.
15. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 2003;39:1071-84.
16. Ince N, Wands R. The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999;340:798-9.
17. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5-S16.
18. Tanaka Y, Hasegawa I, Kato T, Orito E, Hirashima N, Acharya SK, et al. A case control study for difference among hepatitis B virus infections of genotype A (subtype Aa and Ae) and D. Hepatology 2004;40:747-55.
19. Hazari S, Panda SK, Gupta SD, Batra Y, Singh R, Acharya SK. Treatment of hepatitis C virus infection in patients of Northern India. J Gastroenterol Hepatol 2004;19:1058-65.
20. Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, et al. Profile of hepatocellular carcinoma in India. An insight into the possible etiologic associations. J Gastronterol Hepatol 2001;16:666-73.
21. Batra Y, Gulati M, Paul SB, Acharya SK. Clinical profile and results of therapy in patients of HCC at a tertiary care center in India (Abstract). J Gastroenterol Hepatol 2004;19:A799.
22. Thyagarajan S P, Jayaram S, Mohanavally B. Prevalence of HBV in the general population of India. In: Sarin SK, Singa AK, Eds. Hepatitis B in India: Problems and Prevention. New Delhi: CBS Publishers. 1996; p. 5-16.
23. Shah S, Thakkar B, Ahuja H, Sawant P, Desai HG. Prevalence of hepatitis C virus antibody in voluntary replacement blood donors in Mumbai (Abstract). Indian J Gastroenterol 1998;17:S6.
24. Deshpande SS, Khodaiji S. Prevalence of hepatitis C virus antibody in healthy blood donors (Abstract). Indian J Gastroenterol 1998;17:S5.
25. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarathy S, et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver disease. J Med Virol 1997;51:167-74.
26. Paul SB, Acharya SK, Sreenivas V, Gulati MS, Madan K, Gupta AK, et al. Economic evaluation of screening program of patients of cirrhosis for hepatocellular carcinoma (Abstract). J Gastroenterol Hepatol 2006;21:A467.